Replimune

-$0.11 (-0.59%) Today
$0.00 (0.00%) As of 8:16 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Replimune and other ETFs, options, and stocks.

About REPL

Replimune Group, Inc. is a clinical-stage biotechnology company, which engages in the development of oncolytic immunotherapy product candidates through immulytic platform. Its product candidates include RP1, RP2, and RP3.

CEO
Philip Astley-Sparke
Employees
206
Headquarters
Woburn, Massachusetts
Founded
2015

REPL Key Statistics

Market cap
908.78M
Price-Earnings ratio
—
Dividend yield
—
Average volume
367.52K
High today
$18.90
Low today
$17.55
Open price
$18.43
Volume
737.38K
52 Week high
$40.22
52 Week low
$13.05

REPL News

Simply Wall StJun 24

Replimune Group, Inc. Shares Could Be 23% Below Their Intrinsic Value Estimate - Simply Wall St

In this article we are going to estimate the intrinsic value of Replimune Group, Inc. ( ) by estimating the company's future cash flows and discounting them to

REPL Earnings

-$1.75
-$1.17
-$0.58
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Q1 FY23
Estimated
— per share
Actual
Expected Aug 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure